ReliaBull

AMFI Registered Mutual Fund Distributor

Mutual Fund Research

MORE FROM MUTUAL FUNDS

Nippon India Pharma Fund(G)

As on Apr-25-2024 change fund
427.18  up4.56 (1.08%)

fund objective

The primary investment objective of the Scheme is to generate consistent returns by investing in equity / equity related or fixed income securities of Pharma and other associated companies

riskometer

Investors understand that their principal will be at very high risk

5-Years History
financial year2019-20202020-20212021-20222022-20232023-2024
NAV in Rs (as on 31-Mar-2024)143.39250.18290.14270.59428.87
Net Assets(Rs Crores) (as on 31-Mar-2024) 2189.84 4260.99 4931.89 4304.46 7125.28
Scheme Returns(%)(Absolute)-5.8377.3614.83-6.8558.24
B'mark Returns(%)(Absolute)NANANANANA
Category Rank14/7532/7543/7565/7617/90
Quarterly performance - Last 5 years (Absolute Ret. in %)
financial year Q1 Q2 Q3 Q4
2023-202417.1011.2311.589.06
2022-2023-10.128.200.15-4.25
2021-202222.060.731.97-7.50
2020-202131.5919.5012.24-1.15
2019-2020-6.50-1.118.38-5.70
Top 10 holdings
company (%)
Sun Pharmaceutical Industries...14.91 
Lupin Ltd.8.40 
Cipla Ltd.6.51 
Apollo Hospitals Enterprise Ltd.5.79 
Dr. Reddy's Laboratories Ltd.4.75 
Gland Pharma Ltd.4.40 
Divi's Laboratories Ltd.4.36 
Zydus Lifesciences Ltd.4.18 
JB Chemicals & Pharmaceuticals...3.44 
Abbott India Ltd.3.29 

Category

Sector Funds

Launch Date

05-Jun-04

Scheme Benchmark

S&P BSE HEALTH CARE - TRI

AUM ( in Cr.)

7,125.28

portfolio price to book value

7.78

investing style?

Large Growth

fund manager?

Sailesh Raj Bhan

inception date (regular plan)

05-Jun-04

expense ratio (regular plan) %

1.83

Top 10 sectors
sectors (%)
Pharmaceuticals & Drugs80.92
Hospital & Healthcare Services15.13
Business Support1.11

Growth Chart of the Scheme vis a vis benchmark (SIP value 10,000)

to go
  • 1M
  • 3M
  • 6M
  • 1Y
  • 3Y
  • 5Y
  • 10Y
  • maximum
performance comparision with similar schemes and benchmark
scheme name investment style inception date AUM in Cr. 1Y(%) 3Y(%) 5Y(%) 10Y(%) since inception
Nippon India Pharma Fund(G)Large-Growth 05-Jun-20047,125.2852.3516.0322.6716.9820.76
ICICI Pru Pharma Healthcare & Diagnostics (P.H.D) Fund-(G)Large-Growth 13-Jul-20183,772.3258.9417.8824.49NA21.35
SBI Healthcare Opp Fund-Reg(G)Large-Growth 14-Jul-19992,626.3454.5017.8023.1615.4216.11
DSP Healthcare Fund-Reg(G)Large-Growth 30-Nov-20182,352.3251.8216.4925.51NA24.33
Tata India Pharma & Healthcare Fund-Reg(G)Large-Growth 28-Dec-2015878.7053.1016.3522.08NA11.65
Mirae Asset Healthcare Fund-Reg(G)Large-Growth 02-Jul-20182,235.1549.4815.5623.76NA21.58
Aditya Birla SL Pharma & Healthcare Fund-Reg(G)Large-Growth 10-Jul-2019699.5555.9414.73NANA22.29
UTI Healthcare Fund-Reg(G)Large-Growth 01-Aug-2005947.2650.5614.0220.9713.7218.03
LIC MF Healthcare Fund-Reg(G)Large-Growth 28-Feb-201961.6947.5311.2118.96NA18.60
ITI Pharma & Healthcare Fund-Reg(G)Large-Growth 08-Nov-2021160.3947.60NANANA13.22
HDFC Pharma and Healthcare Fund-Reg(G)Large-Growth 04-Oct-2023800.65NANANANA25.14
WOC Pharma and Healthcare Fund-Reg(G)Large-Growth 06-Feb-2024108.61NANANANA0.72
Kotak Healthcare Fund-Reg(G)Large-Growth 11-Dec-2023284.18NANANANA12.99
Quant Healthcare Fund-Reg(G)Large-Growth 17-Jul-2023264.51NANANANA38.39
Attention InvestorsKYC
Contact Us

Mobile No : +91 99674 32226
Tel : 22702326
Email id : assist@reliabullwealth.com

OUR OFFICE

ReliaBull Financial Services Private Limited,
No 4-D, 4th Floor, Victoria Plaza,
SV Road, Above Kora Showroom,
Santacruz West,
Mumbai – 400054

Informations : 
Useful Links : 
Subscribe

For all the Latest Market News, Investment Ideas.

GET OTP
subscribe
Follow us

AMFI Registration No:88227

A Reliabull Financial Services Venture

Designed & Developed by ●●● Accord Fintech Pvt. Ltd.